Tarsus Pharmaceuticals takes in $60 mln Series B

Irvine, California-based Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, has secured $60 million in Series B financing.

Irvine, California-based Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, has secured $60 million in Series B financing. Vivo Capital led the round with participation from other backers that included Frazier Healthcare Partners, Flying L Partners, Visionary Ventures, Aperture Venture Partners and Horowitz Group.

Source: Press Release